JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB209899

Anti-AKR1C3+AKR1C4 抗体 [EPR16726]

Anti-AKR1C3+AKR1C4 antibody [EPR16726]

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Recombinant Monoclonal AKR1C3 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications.

查看别名

DDH1, HSD17B5, KIAA0119, PGFS, AKR1C3, Aldo-keto reductase family 1 member C3, 17-beta-hydroxysteroid dehydrogenase type 5, 3-alpha-hydroxysteroid dehydrogenase type 2, Chlordecone reductase homolog HAKRb, Dihydrodiol dehydrogenase 3, Dihydrodiol dehydrogenase type I, HA1753, Prostaglandin F synthase, Testosterone 17-beta-dehydrogenase 5, 17-beta-HSD 5, 3-alpha-HSD type 2, DD-3, DD3

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized A549 (Human lung carcinoma cell line) cells labeling AKR1C3 with ab209899 at 1/100 dilution followed by Goat anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing cytoplasmic staining on A549 cell line.

The nuclear counterstain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (Alexa Fluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).

The negative controls are as follows : -

-ve control 1 : ab209899 at 1/100 dilution followed by ab150120 at 1/1000 dilution.

-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Flow Cytometry (Intracellular) - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed A549 (Human lung carcinoma cell line) cells labeling AKR1C3with ab209899 at 1/70 dilution (red) compared with a Rabbit IgG,monoclonal- Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluor® 488) at 1/500 dilution was used as the secondary antibody.

Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling AKR1C3 with ab209899 at 1/100 dilution followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing cytoplasmic staining on HepG2 cell line.

The nuclear counterstain is DAPI (blue).

Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).

The negative controls are as follows : -

-ve control 1 : ab209899 at 1/100 dilution followed by ab150120 at 1/1000 dilution.

-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Immunoprecipitation - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
  • IP

Supplier Data

Immunoprecipitation - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

AKR1C3 was immunoprecipitated from 1mg of HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate with ab209899 at 1/30 dilution.

Western blot was performed from the immunoprecipitate using ab209899 at 1/1000 dilution.

VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HepG2 whole cell lysate, 10μg (Input).

Lane 2 : ab209899 IP in HepG2 whole cell lysate.

Lane 3 : Rabbit IgG,monoclonal - Isotype Control (ab172730) instead of ab209899 in HepG2 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 1 second.

All lanes:

Immunoprecipitation - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899)

Predicted band size: 37 kDa

false

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
  • WB

Supplier Data

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/2000 dilution

Lane 1:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate (control) at 10 µg

Lane 2:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg with AKR1C3 peptide on the membrane

Lane 3:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 10 µg with AKR1C4 peptide on the membrane

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 37 kDa

Observed band size: 37 kDa

false

Exposure time: 3min

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
  • WB

Lab

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

Blocking and dilution buffer : 5% NFDM/TBST

Lanes 1 - 4:

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/1000 dilution

Lanes 1 - 4:

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] - BSA and Azide free (<a href='/products/primary-antibodies/akr1c3akr1c4-antibody-epr16726-bsa-and-azide-free-ab251511'>ab251511</a>) at 1/1000 dilution

Lane 1:

His-tagged human AKR1C1 recombinant protein, full-length

Lane 2:

His-tagged human AKR1C2 recombinant protein, full-length

Lane 3:

His-tagged human AKR1C3 recombinant protein, full-length

Lane 4:

His-tagged human AKR1C4 recombinant protein, full-length

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/20000 dilution

Observed band size: 39 kDa

false

Exposure time: 10s

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)
  • WB

Supplier Data

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (AB209899)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1/3 : 2 seconds; Lane 2 : 30 seconds.

Lanes 1 - 2:

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/1000 dilution

Lane 3:

Western blot - Anti-AKR1C3+AKR1C4 antibody [EPR16726] (ab209899) at 1/5000 dilution

Lane 1:

Human fetal kidney lysate at 20 µg

Lane 2:

MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate at 20 µg

Lane 3:

A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 37 kDa,90 kDa

Observed band size: 37 kDa

false

不同偶联物与剂型 (1)

  • Carrier free

    Anti-AKR1C3+AKR1C4 antibody [EPR16726] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR16726

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

Flow Cyt (Intra), IP, ICC/IF, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/70", "FlowCytIntra-species-notes": "<p></p>" } } }

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The proteins AKR1C3 and AKR1C4 also known as Aldo-Keto Reductase Family 1 Member C3 and C4 are reductases involved in the metabolism of steroids prostaglandins and xenobiotics. AKR1C3 has a molecular mass of approximately 37 kDa while AKR1C4 is slightly larger at around 37.2 kDa. These proteins are expressed mainly in the liver but you can also find AKR1C3 in adrenal glands and prostate tissues. Current research shows their functions in enzymatic reduction processes significantly affect hormone conversion and lipid metabolism.
Biological function summary

The proteins AKR1C3 and AKR1C4 have significant roles in steroid hormone metabolism. They do not form a part of any larger complex but act independently to catalyze the conversion of active androgens and estrogens. AKR1C3 for example converts androstenedione to testosterone and estrone to estradiol affecting steroid balance in tissues. Meanwhile AKR1C4 primarily catalyzes the reduction of bile acid intermediates assisting in maintaining liver health and function.

Pathways

AKR1C3 and AKR1C4 operate closely in metabolic pathways involving steroid metabolism and bile acid biosynthesis. In the steroid metabolism pathway they associate with other enzymes like 5α-reductase and CYP19A1 (aromatase) to regulate the conversion and amplification of steroid hormones. In bile acid biosynthesis AKR1C4 works conjointly with enzymes like CYP7A1 playing a significant role in processing cholesterol substrates into bile acids important for lipid digestion and absorption.

AKR1C3 and AKR1C4 have associations with conditions such as prostate cancer and liver disease. AKR1C3's upregulation correlates with prostate cancer progression by influencing androgen receptor activation. It relates to enzymes like CYP17A1 which share involvement in androgen biosynthesis. Meanwhile AKR1C4 plays a role in liver diseases such as cholestasis and is thought to interact with proteins involved in bile transport and synthesis potentially impacting pathological bile acid accumulation. Understanding these interactions helps inform therapeutic strategies targeting hormone and bile acid-related disorders.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Cytosolic aldo-keto reductase that catalyzes NADPH-dependent reduction of ketosteroids to hydroxysteroids. Displays broad substrate specificity with distinct positional and stereochemistry, primarily generating 17beta-hydroxysteroids, but also 3alpha- and 20alpha-hydroxysteroids (PubMed : 10998348, PubMed : 11165022, PubMed : 20036328, PubMed : 9415401, PubMed : 9927279, PubMed : 10998348, PubMed : 9927279). Produces potent androgens via classical and 'backdoor'/alternative pathways. In the classical androgen metabolic pathway (biosynthesis of 5alpha-dihydrotestosterone (5alpha-DHT) via testosterone), catalyzes the reduction of delta4-androstenedione to form testosterone (PubMed : 10998348, PubMed : 11165022, PubMed : 20036328, PubMed : 9415401, PubMed : 9927279). In the 'backdoor' androgen metabolic pathway (biosynthesis of 5alpha-dihydrotestosterone (5alpha-DHT) via pregnanes), reduces androsterone to 5alpha-androstane-3alpha,17beta-diol preceding 5alpha-DHT secretion (PubMed : 10557352, PubMed : 10998348, PubMed : 9415401). Reduces 5alpha-DHT to less potent androgen 5alpha-androstane-3alpha,17beta-diol, likely regulating ligand availability for androgen receptors (PubMed : 10557352, PubMed : 10998348, PubMed : 11165022, PubMed : 14672942, PubMed : 7650035, PubMed : 9415401). May contribute to the metabolism of adrenal-derived androgen precursors. Reduces 11-keto-4-androstene-3,17-dione (11KA4) and 11-keto-5alpha-androstane-3,17-dione (11K-Adione) into potent androgens 11-ketotestosterone (11KT) and 11-ketodihydrotestosterone (11KDHT), respectively (PubMed : 31926269). In estrogen metabolism, catalyzes the conversion of estrone to potent estrogen 17beta-estradiol (PubMed : 10998348, PubMed : 11165022, PubMed : 20036328). Acts as a prostaglandin (PG) F2alpha synthase. Displays 11-ketoreductase and 9,11-endoperoxide reductase activities and reduces PGD2 to 11beta-PGF2alpha and PGH2 to PGF2alpha (PubMed : 10622721, PubMed : 11165022, PubMed : 15047184, PubMed : 19010934, PubMed : 20036328, PubMed : 7650035, PubMed : 9415401, PubMed : 9927279). Also displays retinaldehyde reductase activity toward 9-cis-retinal (PubMed : 21851338). In vitro can efficiently catalyze bidirectional conversion between ketosteroids and hydroxysteroids using NADPH/NADP(+) or NADH/NAD(+) as cofactors. In vivo however, the reductase activity prevails since the major reducing cofactor NADPH inhibits NAD(+)-dependent oxidase activity (PubMed : 11165022, PubMed : 14672942). In addition, it is able to reduce in vitro various carbonyl compounds like menadione, phenanthrenequinone and nitrobenzaldehyde (By similarity).
See full target information AKR1C3

其他靶点

AKR1C4

文献 (10)

Recent publications for all applications. Explore the full list and refine your search

iScience 28:111808 PubMed39995859

2025

Identification of meibomian gland testosterone metabolites produced by tissue-intrinsic intracrine deactivation activity.

Applications

Unspecified application

Species

Unspecified reactive species

Khanh Tien Nguyen Pham,Takahito Miyake,Tomo Suzuki,Shigeru Kinoshita,Yuki Hamada,Hikari Uehara,Mamiko Machida,Takeshi Nakajima,Emi Hasegawa,Masao Doi

Theranostics 14:7623-7644 PubMed39659569

2024

Intranasal delivery of engineered extracellular vesicles loaded with miR-206-3p antagomir ameliorates Alzheimer's disease phenotypes.

Applications

Unspecified application

Species

Unspecified reactive species

Dong Peng,Tingting Liu,Huahui Lu,Lei Zhang,Hongxia Chen,Yadong Huang,Bo Hu,Qihao Zhang

Aging 15:3807-3825 PubMed37166429

2023

Identification and validation of metabolism-related genes signature and immune infiltration landscape of rheumatoid arthritis based on machine learning.

Applications

Unspecified application

Species

Unspecified reactive species

Zhaoyang Guo,Yuanye Ma,Yaqing Wang,Hongfei Xiang,Huifei Cui,Zuoran Fan,Youfu Zhu,Dongming Xing,Bohua Chen,Hao Tao,Zhu Guo,Xiaolin Wu

Endocrinology 164: PubMed36799021

2023

Insulin-Induced AKR1C3 Induces Fatty Acid Synthase in a Model of Human PCOS Adipocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Ryan D Paulukinas,Trevor M Penning

Journal of nanobiotechnology 21:55 PubMed36803994

2023

Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.

Applications

Unspecified application

Species

Unspecified reactive species

Zijian Su,Yibo Zhang,Jieqiong Cao,Yuanmeng Sun,Yuling Cai,Bihui Zhang,Liu He,Zilei Zhang,Junye Xie,Qilin Meng,Lin Luo,Fu Li,Jingsheng Li,Jinting Zhang,Xiaojia Chen,An Hong

Frontiers in oncology 12:849242 PubMed35646665

2022

A Novel and Robust Prognostic Model for Hepatocellular Carcinoma Based on Enhancer RNAs-Regulated Genes.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Zhang,Kegong Chen,Wei Tian,Qi Zhang,Lin Sun,Yupeng Wang,Meina Liu,Qiuju Zhang

Scientific reports 12:5809 PubMed35388063

2022

AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker.

Applications

Unspecified application

Species

Unspecified reactive species

Deepti Reddi,Brandon W Seaton,David Woolston,Lauri Aicher,Luke D Monroe,Zhengwei J Mao,Jill C Harrell,Jerald P Radich,Anjali Advani,Nikolaos Papadantonakis,Cecilia C S Yeung

Frontiers in oncology 12:823491 PubMed35359392

2022

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jia Zheng,Zhihong Yang,Yanlei Li,Li Yang,Ruili Yao

Archives of toxicology 94:3059-3068 PubMed32588086

2020

Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens?

Applications

Unspecified application

Species

Unspecified reactive species

Eva Novotná,Anselm Morell,Neslihan Büküm,Jakub Hofman,Petra Danielisová,Vladimír Wsól

Reproduction (Cambridge, England) 158:493-501 PubMed31671404

2019

Endometrial stromal cell miR-29c-3p regulates uterine contraction.

Applications

Unspecified application

Species

Unspecified reactive species

Lan Xiao,Qiong Zhang,Xi Huang,Aihua He,Shi Xie,Yanping Li
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com